Sign In
Buy WGS
$53.02
-0.110 (-0.207%)
At Close: Jun 03, 2026
Will Robust Exome and Genome Growth Boost WGS' Q1 Earnings Results?
11:00am, Monday, 21'st Apr 2025
GeneDx is expected to have continued the strong 2024 momentum across all metrics in the first quarter of 2025.
GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale
06:00am, Wednesday, 16'th Apr 2025
GAITHERSBURG, Md. & OAKLAND, Calif.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS) today announced its plans to acquire Fabric Genomics, a pioneer in AI-powered genomic interpretation.
GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025
08:05am, Tuesday, 08'th Apr 2025
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx today announced it will release financial results for the first quarter of 2025 before the market opens on Wednesday, April 30, 2025.
Buy 3 Momentum Anomaly Stocks as Markets Rise Despite Tariff Threats
10:35am, Wednesday, 02'nd Apr 2025
GME, WGS and APP are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Thursday, 20'th Mar 2025
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx today announced inducement grants under Nasdaq Listing Rule 5635(c)(4).
Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies
07:05am, Tuesday, 18'th Mar 2025
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS) announced today they have been named to Fast Company's prestigious list of the World's Most Innovative Companies of 2025.
5 Stocks With Recent Price Strength Amid Extreme Volatility
06:50am, Tuesday, 18'th Mar 2025
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are DRD, WGS, EVER, HCI, BABA.
GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting
08:30am, Thursday, 13'th Mar 2025
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced today its scientific contributions will be presented at th
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Multiscore, an advanced AI-powered decision support
GeneDx Holdings: There Is Upside Potential, But Price Tag Is Rich
01:13pm, Wednesday, 12'th Mar 2025
GeneDx Holdings Corp. is delivering strong revenue growth, but it is still burning cash, which makes me hesitant. At 7x sales, WGS stock feels expensive, given its current financials. If GeneDx can pr
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS
12:19pm, Tuesday, 11'th Mar 2025
NEW YORK , March 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of GeneDx Holdings Corp ("GeneDx" or the "Company") (NASDAQ: WGS). Such investors are advised to
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS
10:00am, Friday, 07'th Mar 2025
NEW YORK, NY / ACCESS Newswire / March 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of GeneDx Holdings Corp ("GeneDx" or the "Company") (NASDAQ:WGS). Such investors are advis
How This Top Small-Cap Growth Fund Wins Big
07:00am, Friday, 07'th Mar 2025
In a stock market that favors the giants, it's still possible to reap big gains investing in Wall Street's small fries. The post How This Top Small-Cap Growth Fund Wins Big appeared first on Investor'
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS
02:30pm, Wednesday, 05'th Mar 2025
Pomerantz LLP is investigating claims on behalf of investors of GeneDx Holdings Corp ("GeneDx" or the "Company") (NASDAQ:WGS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp - WGS
01:09pm, Monday, 03'rd Mar 2025
NEW YORK , March 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of GeneDx Holdings Corp ("GeneDx" or the "Company") (NASDAQ: WGS). Such investors are advised to
